Soft Tissue Tumors

Neutron therapy is appropriate for the following histologies:

  • Alveolar soft tissue sarcoma
  • Angiosarcoma
  • Epithelioid sarcoma
  • Ewing's sarcoma
  • Fibrosarcoma
  • Hemangioendothelial sarcoma
  • Hemangiopericytoma
  • Histiocytoma, atypical or malignant fibrous
  • Leiomyosarcoma
  • Liposarcoma
  • Neurofibrosarcoma
  • Rhabdomyosarcoma
  • Synovial cell sarcoma
Patients who may benefit from neutron therapy include:
  • Newly diagnosed patients with unresectable (inoperable) disease, or residual disease following surgery (positive margins).
  • Patients whose disease has recurred after surgery.
  • Patients who want to avoid the surgical option of amputation.


For general questions please contact neutrons@fnal.gov   Or call 630-840-3865
Security, Privacy, LegalFermi National Accelerator Laboratory

Security, Privacy, Legal